Brian Kaye is a Rheumatology/Immunology physician affiliated with University of California, San Francisco. OpenAlex indexes 12 publications with 928 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2850 Telegraph Ave
Suite 120
Berkeley, CA 947051192
Telephone
510-845-2529Registry record last updated 16 Jul 2007.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Surgenex LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
32.2%RANK Ligand Inhibitor23.8%Denosumab100%Part B, office-administered≥12 patientsXanthine oxidase inhibitor4.6%Allopurinol80%Febuxostat20%Part D<11 patients+ 2 more classes in this area
Dermatology
25.4%Corticosteroid25.4%Triamcinolone acetonide99%Triamcinolone Acetonide1%Part D + Part B<11 patientsCancer & immunology
19.7%TNF inhibitor7.5%Humira(Cf) Pen60%Enbrel Sureclick18%Humira(Cf)18%Enbrel5%Part D<11 patientsFolate Analog Metabolic Inhibitor7.3%Methotrexate100%Part D≥113 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus
The American Journal of Medicine
1995 - Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy.
Annals of the Rheumatic Diseases
1992 - Rheumatologic Manifestations of Infection with Human Immunodeficiency Virus (HIV)
Annals of Internal Medicine
1989
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”